eHealth Ventures, an Israel-based digital health incubator, is to launch operations with backing from a consurtium of industry leading investors.
Backers include Amgen (Europe) GmbH, an affiliate of Amgen Inc. (NASDAQ: AMGN), US hospital Cleveland Clinic, Israel-based health provider Maccabi Healthcare Services, and Medison Pharma, Israel-based independent specialty pharmaceutical company and Amgen’s distributor in Israel.
Launched in March of 2016 with Israeli government backing and led by Talor Sax, chief executive officer, eHealth Ventures aims to invest in 40 digital health companies over an eight year period.
Press Release
Amgen To Invest In Israel-Based eHealth Ventures
Amgen Builds its Digital Health Capabilities Through Investment in Leading Digital Health Incubator
ZUG, Switzerland, Oct. 25, 2016 – Amgen (Europe) GmbH, an affiliate of Amgen Inc. (NASDAQ: AMGN) (collectively, “Amgen”) today announced an investment in eHealth Ventures, an Israel-based digital health incubator. The investment reflects Amgen’s commitment to serving patients by driving innovation and sustainable healthcare through technology discovery, and recognizes the importance of Israel as a source of innovation in eHealth and digital technologies. Additional investors include Israeli HMO Maccabi Healthcare Services and Amgen’s Israeli distributor Medison Pharma Ltd. Amgen will be the lead biopharmaceutical investor.
“Engaging in multi-stakeholder partnerships will drive innovation and enable us to deliver additional value to patients and the healthcare community, beyond our life-saving medicines,” said Corinne Le Goff, senior vice president, Amgen Europe. “This collaboration with eHealth Ventures is a natural fit for Amgen and will help us expand our digital health pipeline and support the growth of valuable health technology to improve the lives of patients across the world.”
“We are proud to have Amgen, a global market leader, join the eHealth Ventures unique consortium together with Maccabi Healthcare Services, Cleveland Clinic and Medison Pharma. This addition will provide a new strategic element to our screening process and build significant value to our portfolio companies. Having Amgen on board will deliver invaluable assets and know-how in many of the digital health innovation aspects, including market input, commercialization of R&D, business modeling, go-to-market strategies and more,” said Talor Sax, eHealth Ventures Incubator chief executive officer. “We are grateful to our partner Medison Pharma, for realizing this vision and making this partnership a reality.”
About eHealth Ventures
eHealth Ventures, a consortium of world-class organizations and investors active in the field of digital health, was launched in March of 2016 with Israeli government backing. The consortium, which comprises Cleveland Clinic, a leading US hospital, Maccabi Healthcare Services, Israel’s leading and most advanced health provider, and Medison Pharma, Israel’s largest independent specialty pharmaceutical company and Amgen’s distributor in Israel, aims to invest in 40 new companies over an eight year period.
FinSMEs
26/10/2016